Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 10, 2018
Inceptua Group announces that Maria Eklind-Cervenka joins as new Chief Medical Officer (CMO).
read more
Biotage is one of the few companies offering a complete solution and ready to go off-the-shelf products for the purification of large-scale lipids, used in mRNA vaccine development and production. Expanding its production capacity of large-scale ...
read more
Tuesday, November 23, 2021
Baidu, Inc. and Sanofi have entered into an agreement to integrate Baidu's messenger ribonucleic acid (mRNA) design optimization platform, LinearDesign, into Sanofi's product design pipeline.
read more
Thursday, February 28, 2019
Bioinfogate has entered into a global agreement with Clarivate Analytics to cross-link the OFF-X translational safety intelligence portal with Cortellis preclinical intelligence.
read more
A new £56 million UK innovation centre, which will revolutionise how medicines are manufactured, is to be located in Renfrewshire.
read more
NeuroTrauma Sciences and Henry Ford Health System announced a newly-formed subsidiary of NTS has entered into multi-year Sponsored Research and License Agreements.
read more
NeuroRx, in partnership with Relief, announced the independent Data Monitoring Committee has reviewed the findings in the first 30 patients treated in Fast Track trials of Aviptadil in patients with Critical COVID-19 with respiratory failure.
read more
Tuesday, January 14, 2020
Neurocrine Biosciences and Idorsia announced an amendment to the agreement granting Neurocrine Biosciences an option to license ACT-709478 for a rare pediatric epilepsy.
read more
Monday, February 13, 2017
Neurocrine Biosciences and BIAL have entered into an exclusive licensing agreement for the development and commercialization of opicapone in North America. ONGENTYS® (opicapone) is a once-daily, peripherally-acting, highly-selective catechol-O-...
read more
Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned as client demand increases. The first of four planned modules is ...
read more
Neuland Laboratories has brought online a fully operational dedicated Process Engineering Lab at its R&D Center.
read more
LSNE continues their expansion with the addition of increased cGMP storage capabilities at its 7 Commerce Drive facility located in Bedford, New Hampshire.
read more
Friday, September 14, 2018
Nephron Pharmaceuticals is currently producing medications at its West Columbia, S.C. facility while monitoring the effects of Hurricane Florence.
read more
Neovii has signed a research and license agreement with Tel Aviv University to develop a novel COVID-19 vaccine.
read more
Neovii and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon, in China and Japan.
read more